The 10 mg/kg dose resulted in 80 percent CD47 occupancy on splenic T cells twenty-four hours post-dose, while only 21 and 43 percent occupancy was observed for tumor cells and T cells, respectively, in the tumor compartment. The gene discussed is CD47; the disease is neoplasm.